Iroko reports positive results from Phase III submicron indomethacin and diclofenac studies

Iroko Pharmaceuticals has reported positive results from its Phase III studies of lower dose submicron indomethacin in patients with post-surgical pain, and lower dose submicron diclofenac in patients with osteoarthritis pain.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news